Skip to content

A study to see how type 2 diabetes affects memory and thinking, and whether yoga can help improve them

A STUDY TO EVALUATE THE COGNITIVE DECLINE IN TYPE 2 DIABETES AND YOGA INTERVENTION - Mindcare-D

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094970
Enrollment
132
Registered
2025-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Yoga: 45 minutes of yoga session for 24 weeks Control Intervention1: NA: NA

Sponsors

Krishnamacharya Yoga Mandiram
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: HbA1c greater than or equal to 7.0 to lesser than 10.5 All patients must give written informed consent

Exclusion criteria

Exclusion criteria: Type 1 Diabetes mellitus Patients with a serum creatinine concentration greater than 132.6 mmol/L (1.5 mg/dL) or liver function impairment (AST and ALT 2.5 times upper limit of normal range) Patients have laboratory test abnormality (biochemistry, haematology, or urinalysis) Patients with significant alcohol, drug or medication abuse Currently under a psychiatrist s care or using antipsychotic or mood stabilizer medication or have diagnosed dementia or bipolar disorder or schizophrenia. Pregnant or lactating Had a documented CVD event (MI, stroke) in past 12 months Participation is purely voluntary and there will be no coercion by the consenter. Participants will not receive material compensation to join the study. All participants will be assured that they have the right to voluntarily withdraw from the study at any time and that withdrawal will not affect their future medical care. Participants will also be told that their diabetes care provider will be notified of their stress and depressive symptoms.

Design outcomes

Primary

MeasureTime frame
To assess the cognitive status in patients with type 2 diabetes Improvement in cognitive function from baseline to 24 weeks Timepoint: 24 weeks

Secondary

MeasureTime frame
Improvement in Quality of life from baseline to 12 weeks Change in HbA1c from baseline to 24 weeks Change in BMI from baseline to 24 weeks Change in blood pressure from baseline to 24 weeks Change in other biochemical parameters from baseline to 24 weeksTimepoint: 24 weeks

Countries

India

Contacts

Public ContactDr S Poongothai

Madras Diabetes Research Foundation

poongothaisubramani@gmail.com9840134505

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026